Losortan Potassium
Product Images NDC 45865-684
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 45865-684). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Figure1)
This appears to be a graph or chart showing the percentage of patients with a particular primary endpoint for two different medications, Atenolol and Losartan Potassium, over a period of 66 months. The adjusted risk reduction and p-value are also provided. Without more context or additional information, it is difficult to provide a more specific description of the data.*
Figure2 (Figure2)
This is a medical-related text mentioning two drugs, Atenolol and Losartan Potassium. The text also displays a statistic of adjusted risk reduction of 25% with a p-value of 0.001, related to some sort of study. The rest of the text seems to represent a graph, displaying study months or time periods.*
Figure3 (Figure3)
Figure4 (Figure4)
This is a clinical trial result demonstrating the efficacy of Losartan Potassium Tablet in reducing risks of an event in comparison to a placebo. The percentage of patients with an event is 40 and the risk reduction offered by Losartan Potassium Tablet is 16.1%. The P-value is 0.022. The numbers at the bottom could represent a time period.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.